See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626971_2018_Corvus_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001626971')"} |
Graph
Absolute values for 0001626971, Corvus Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 91,234,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,672,000 |
| 3 | remainder_Assets | 869,000 |
| 4 | LiabilitiesCurrent | 8,969,000 |
| 5 | LiabilitiesNoncurrent | 971,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,219,000 |
| 9 | ResearchAndDevelopmentExpense | 46,305,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 861,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 94,775,000 |
| 1 | Liabilities | 9,940,000 |
| 2 | Expenses | 56,524,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 84,835,000 |
| 5 | NetIncome | -55,663,000 |
| 6 | ComprehensiveNetIncome | -55,664,000 |
| 7 | BaseVar | 81,051,000 |
| 8 | EconomicCapitalRatio | 1.72 |
Edgar->Model Mapping
Feature Distribution
Change over Time
